Citation 121747

MARTINEZ,LA: RIOS,JL: PAYA,M: ALCARAZ,MJ:. (1992). INHIBITION OF NONENZYMIC LIPID PEROXIDATION BY BENZYLISOQUINOLINE ALKALOIDS.. 12(4)

Citation Details

Title	INHIBITION OF NONENZYMIC LIPID PEROXIDATION BY BENZYLISOQUINOLINE ALKALOIDS.
Authors	MARTINEZ,LA: RIOS,JL: PAYA,M: ALCARAZ,MJ:
Year	1992
Volume	12
Issue	4

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANONAINE	ACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERBERINE	INACTIVE
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BERBERINE,TETRAHYDRO:	ACTIVE
4	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BICUCULLINE,(+):	INACTIVE
5	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BULBOCAPNINE	ACTIVE
6	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BOLDINE,ISO:	ACTIVE
7	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BOLDINE	ACTIVE
8	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHELIDONINE	INACTIVE
9	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLAUCINE	ACTIVE
10	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LAUDANOSINE	INACTIVE
11	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LAUDANOSOLINE	ACTIVE
12	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARCEINE	INACTIVE
13	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOSCAPINE	INACTIVE
14	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORPHINE,APO:	ACTIVE
15	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PAPAVERINE	INACTIVE
16	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PAPAVERINE,PROTO:	ACTIVE
17	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STEPHOLIDINE	WEAK ACTIVITY
18	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RETICULINE	INACTIVE
19	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE	INACTIVE

Show SPARQL Queries (1)